Cytotoxicity of pEGFP vector is due to residues encoded by multiple cloning site

Analytical Biochemistry

Volumn 313, Issue 2, 2003, Pages 345-347

  Endemann, Gerda ^a   Schechtman, Deborah ^a   Mochly Rosen, Daria ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

MULTIPLE CLONING;

CLONE CELLS;

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PEPTIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; ROTTLERIN; SERYLGLYCYLARGINYLTHREONYLGLUTAMINYLISOLEUCYLSERYLSERYLSERYLSERYLPHENYLALAN YLGLUTAMYLCYSTEINYLSERYLARGINYLARGINYLTYROSYLARGINYLGLYCYLPROLYLGLYCYLISOLEUCYLH ISTIDYLARGINYLISOLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CYTOTOXICITY; DNA SEQUENCE; DNA VECTOR; EXPRESSION VECTOR; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

VECTORS;

EID: 0037442458     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00619-X     Document Type: Article

References (10)

1. Wahlfors J.et al. Green fluorescent protein (GFP) fusion constructs in gene therapy research. Histochem. Cell. Biol. 115(1):2001;59-65.
2. Liu H.S.et al. Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260(3):1999;712-717.
3. Hanazono Y.et al. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8(11):1997;1313-1319.
4. Kandel E.S.et al. Applications of green fluorescent protein as a marker of retroviral vectors. Somat. Cell. Mol. Genet. 23(5):1997;325-340.
5. Schwarze S.R.et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285(5433):1999;1569-1572.
6. Chen L.et al. Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC. Proc. Natl. Acad. Sci. USA. 98(20):2001;11114-11119.
7. Gschwendt M.et al. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199(1):1994;93-98.
8. Johnson J.A.et al. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271(40):1996;24962-24966.
9. Zhong M., Lu Z., Foster D.A. Downregulating PKCδ provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene. 21(7):2002;1071-1078.
10. Cerda S.R.et al. PKC-δ inhibits anchorage-dependent and -independent growth enhances differentiation and increases apoptosis in CaCo-2 cells. Gastroenterology. 120(7):2001;1700-1712.